top of page
News

Feb 7, 2024
Join us at the Hello Tomorrow online panel discussion on open innovation on February 16 at 3pm
Join Hello Tomorrow, L’Oréals R&I teams (Open Innovation, Advanced Research, and Green Science Incubator), Genopole, and Algentech for an online panel discussion on February 16 at 3 pm for an enriching discussion about open innovation and its role in the advancement of green sciences, biotechnologies, and overall collaboration across different sectors and actors. https://www.linkedin.com/posts/hello-tomorrow-challenge_openinnovation-beautyindustry-biotech-activity-71609832966

Jan 5, 2024
Collaboration entre Algentech et l'Oréal dans le domaine des technologies vertes
https://www.linkedin.com/posts/raise-lab_collaboration-startups-cosmaeztique-activity-7119987860862029824-dsAC?utm_source=share&utm_medium=m

Jan 5, 2024
Algentech is the first company to integrate l'Oréal Green Science Incubator at Genopole
L’Oréal et Genopole topent pour développer la biotech et la cosmétique durable | Les Echos

Jan 5, 2024
Algentech's bioproduction technology selected by the Sanofi Itech Awards
Algentech's bioproduction technology selected by the Sanofi Itech Awards

Nov 10, 2021
Alexander Sorokin, CEO of Algentech, finalist at the EurekAward
Alexander is presenting Algentech’s technology and application to produce sustainable ingredients at this year’s EurekAwards final

Nov 4, 2021
Algentech awarded a grant by the European Space Agency
Algentech has been recently awarded a grant by the European Space Agency via its Open Space Innovation Platform (OSIP).

Jun 25, 2021
Algentech is proud to announce the publication of its breakthrough chloroplast technology in Nature Plants
Algentech’s disruptive technology was published on June 21, 2021 in the journal Nature Plants

May 31, 2021
Neftys Interviews Algentech CSO Isabelle Malcuit
Link to full interview here


Jan 22, 2020
Algentech Granted US Patent For A Key Genome Editing Technology
ALGENTECH, announces the issuance of a key patent in the field of genome editing by the U.S. Patent Office (U.S. patent number 10457950)

Feb 6, 2019
Algentech achieves a major breakthrough in crop genomics
<p>Algentech announces it has solved a major technological bottleneck in applied plant genomics, by transforming the cotton mitochondrial genome with DNA sequences naturally capable of inducing cytoplasmic male sterility. This breakthrough in molecular genetics can be applied in the fast generation of high yielding hybrid varieties without the requirement of repetitive and time-consuming back-crosses, simply […]</p>

Sep 24, 2018
Algentech is among the 135 European companies to join Euronext's Techshare programme
<p>The company was selected to participate in the Techshare class of 2018/2019. Detailed description of the programme can be found here: https://www.euronext.com/en/news/over-100-new-companies-join-euronext-techshare-programme</p>


Jul 18, 2018
BIO World Congress on Industrial Biotechnology
<p>Alexander Sorokin, CEO is at the 2018 BIO World Congress on Industrial Biotechnology held in Philadelphia, July 17-19 2018 (https://www.bio.org/events/bio-world-congress ) The BIO World Congress on Industrial Biotechnology provides a unique forum for business executives, government officials, academic researchers and industry leaders to share the latest advances in renewable chemicals, synthetic biology, enzymes, food ingredients, biofuels, algae and more. […]</p>

Jul 18, 2018
Hydrozyme selected by Superbio
<p>Algentech’s Hydrozyme project has been selected for innovation funding from the SuperBIO Horizon 2020 Project! The Hydrozyme system is designed to use the potential of our chloroplast production platform to generate enzymes involved in bio-hydrogen production using biomass. With SuperBIO’s support we will soon launch pilot studies on our plant cell lines to test for […]</p>


Jun 4, 2018
Alexander Sorokin, CEO and Isabelle Malcuit, CSO will be taking part in the 2018 BIO International Convention held in Boston,MA, June 4-7 2018 (http://convention.bio.org)
<p>Alexander Sorokin, CEO and Isabelle Malcuit, CSO will be taking part in the 2018 BIO International Convention held in Boston,MA, June 4-7 2018 (http://convention.bio.org) Hosted by the Biotechnology Innovation Organization (BIO), it is the world’s largest biotechnology business partnering event, the BIO International Convention will take place at the Convention and Exhibition Center in Boston. Alexander and Isabelle will […]</p>
bottom of page